Dosimetric benefits of adaptive radiation therapy for patients with stage III non-small cell lung cancer

BACKGROUND: Daily adaptive radiation therapy (ART) of patients with non-small cell lung cancer (NSCLC) lowers organs at risk exposure while maintaining the planning target volume (PTV) coverage. Thus, ART allows an isotoxic approach with increased doses to the PTV that could improve local tumor cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoppen, Lea, Sarria, Gustavo R., Kwok, Chung S., Boda-Heggemann, Judit, Buergy, Daniel, Ehmann, Michael, Giordano, Frank A., Fleckenstein, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945670/
https://www.ncbi.nlm.nih.gov/pubmed/36814271
http://dx.doi.org/10.1186/s13014-023-02222-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945670/
https://www.ncbi.nlm.nih.gov/pubmed/36814271
http://dx.doi.org/10.1186/s13014-023-02222-7

Ejemplares similares